PRSS53 is a potential novel biomarker related to prognosis and immunity in clear cell renal cell carcinoma
Abstract Objective To analyze the expression levels, clinical significance, Immune infiltration and prognostic value of PRSS53 (Protease Serine 53) in clear cell renal cell carcinoma (ccRCC) using bioinformatics methods. Methods Data on PRSS53 in ccRCC were extracted from databases and platforms, in...
Saved in:
| Main Authors: | Jiajun Zhang, Guocheng Liu, Wei Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-03-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-02114-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
GAMT facilitates tumor progression via inhibiting p53 in clear cell renal cell carcinoma
by: Bin Zheng, et al.
Published: (2025-04-01) -
Retinoid X receptor γ predicts the prognosis and is associated with immune infiltration in kidney renal clear cell carcinoma: a qRT-PCR, TCGA and in silico research
by: Jianda Dong, et al.
Published: (2025-03-01) -
Prognostic Role of SETDB2 in Clear Cell Renal Cell Carcinoma: Linking Immune Infiltration, Cuproptosis, and Tumor Suppression
by: Lu SH, et al.
Published: (2025-03-01) -
Radiogenomic correlation of hypoxia-related biomarkers in clear cell renal cell carcinoma
by: Yijun Shao, et al.
Published: (2025-06-01) -
PAQR6 as a prognostic biomarker and potential therapeutic target in kidney renal clear cell carcinoma
by: Tao Zou, et al.
Published: (2024-12-01)